April 2014
Volume 55, Issue 13
ARVO Annual Meeting Abstract  |   April 2014
The Role of Nrf-2 in Alternative Pathway (AP) Complement and Hydroquinone (HQ)-mediated Heme Oxygenase-1 (HO-1) Expression in Human RPE (hRPE) Cells
Author Affiliations & Notes
  • Michelle Bao
    Ophthalmology, Duke University Eye Center, Durham, NC
  • Zhe Ma
    Ophthalmology, Duke University Eye Center, Durham, NC
  • Ping Yang
    Ophthalmology, Duke University Eye Center, Durham, NC
  • Peter Baciu
    Biology, Allergan Inc, Irvine, CA
  • Glenn J Jaffe
    Ophthalmology, Duke University Eye Center, Durham, NC
  • Footnotes
    Commercial Relationships Michelle Bao, None; Zhe Ma, None; Ping Yang, None; Peter Baciu, Allergan Inc (E); Glenn Jaffe, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 3435. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Michelle Bao, Zhe Ma, Ping Yang, Peter Baciu, Glenn J Jaffe; The Role of Nrf-2 in Alternative Pathway (AP) Complement and Hydroquinone (HQ)-mediated Heme Oxygenase-1 (HO-1) Expression in Human RPE (hRPE) Cells. Invest. Ophthalmol. Vis. Sci. 2014;55(13):3435.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: Oxidative stress and complement activation are implicated in age-related macular degeneration (AMD). HO-1 is a stress-inducible protein with antioxidant and potential anti-inflammatory effects. We previously reported that complement activation through the AP attenuates HQ-mediated HO-1 mRNA induction. Multiple signaling pathways, including Nrf-2, NF-κB, AP-1, and MAPK, modulate HO-1 expression in non-ocular cells, and Nrf-2 is thought to play an important role. To better understand complement-mediated attenuation of HO-1, we investigated the role of Nrf-2 signaling on HO-1 expression in response to HQ alone, or in combination with AP complement.

Methods: Cultured hRPE were treated with 125 uM HQ for 1.5 hours, primed with sheep anti-ARPE-19 antibody for 30 minutes and incubated in C1q-depleted human serum (C1q-Dep) for 3 hours. To study the role of Nrf-2 in HQ-mediated HO-1 induction, 80% confluent hRPE were transfected with 30 nM of small interfering RNA (siRNA) specific for Nrf-2. Once confluent, cells were exposed to 125 uM HQ for 1.5 hours and incubated in serum-free media for 3.5 hours. Cytoplasmic and nuclear protein was harvested, and protein levels were determined by Western blot. Confluent hRPE were treated with 40 ng/ml TNF-α, various doses of HQ, or AP complement at multiple time points. NF-κB translocation was examined with immunofluorescent staining and western blots of cytoplasmic and nuclear extracts.

Results: AP complement activation attenuated HQ-induced HO-1 protein; the magnitude of this effect varied among experiments. Increased nuclear Nrf-2 accompanied HQ-mediated HO-1 induction, and AP complement attack had minimal effect on HQ-induced Nrf-2 protein. HQ-induced Nrf-2 protein was knocked down by Nrf-2 siRNA, but Nrf-2 inhibition had minimal effect on HQ-induced HO-1. TNF-α caused NF-κB nuclear translocation at 40 and 90 minutes, but HQ and AP complement alone did not cause NF-κB nuclear translocation at any dose or time point.

Conclusions: AP complement activation attenuated HQ-mediated up-regulation of HO-1 protein expression. These phenomena appeared largely Nrf-2 and NF-κB independent. These data suggest that other transcription factors may play more significant HO-1 regulatory roles and represent further targets of study to understand the synergistic effects of oxidative stress and AP activation on RPE cell function.

Keywords: 412 age-related macular degeneration • 701 retinal pigment epithelium • 634 oxidation/oxidative or free radical damage  

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.